Dr. Stephen Matta, DO, MBA, CAQSM, is a triple board-certified physician in Family Medicine, Sports Medicine, and Stem Cell Therapy. He is co-founder of Meeting Point Health in Philadelphia. Specializing in regenerative orthopedics, anti-aging, and cellular medicine, he integrates holistic therapies like ultrasound-guided regenerative injections with orthobiologics, osteopathic manipulation, peptide and hormone therapy, and medical acupuncture to address chronic pain and nervous system dysregulation. A graduate of Philadelphia College of Osteopathic Medicine, Dr. Matta completed his residency at Valley Baptist Family Practice in Texas, and a fellowship in Primary Care Sports Medicine at Mountainside Sports Medicine in New Jersey. His East-meets-West approach, co-developed with his wife, Mary Anne Matta, emphasizes root-cause solutions, utilizing peptides, ozone therapy, and stem cell therapy. Formerly a team physician for the Antigua Professional Soccer Team and NJIT Division I sports, Dr. Matta is a Fellow of the SSRP Institute and a sought-after speaker. His comprehensive assessments and patient-centered care have transformed lives, earning him a reputation as a master diagnostician dedicated to unlocking human potential through integrative medicine.
Article
Dec 10, 2025
Stephen Matta, DO, MBA, CAQSM
Myriah Werne
RELATED RESOURCES
Continue exploring related topics.
VIEW ALL
Medivive
Mar 27, 2026
SSRP Institute Welcomes Medivive as New Trusted Partner
WILLOUGHBY, Ohio, [March 27, 2026] — The SSRP Institute is pleased to announce that Medivive has joined its Trusted Partner Network following nomination and internal vetting aligned with SSRP’s mission of advancing science-first, education-driven clinical collaboration. Medivive offers an advanced approach to NAD⁺ therapy designed to support cellular energetics through sterile, clinician-prescribed formulations produced under […]
READ NEWS
William Seeds, MD
Mar 25, 2026
The Truth about Ketone Esters: Not All Exogenous Products are the Same
The Father of Ketones and the Value of Exogenous Ketone Esters I’ve talked about ketones and ketone esters for many years, and I’ve now come to a place where I really have to take a more direct stand on how they’ve been marketed to the wider public, and in particular, to providers who may not […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Mar 23, 2026
Ep. 080 - BPC-157 vs. TB-500: Evaluating Unexpected Joint Symptoms
Preview Only
Dissecting Protocols – Episode 080
BPC-157 vs. TB-500: Evaluating Unexpected Joint Symptoms
Dr. Seeds reviews a case of swelling, joint stiffness, and tingling that appeared after stacking BPC-157 with TB-500, using it as a framework for thinking through peptide reactions, sourcing, and causality. (Question Link)
Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Mar 16, 2026
Ep. 079 - Sleep Through the Lens of Cellular Medicine
Preview Only
Rabbit Holes – Episode 079
Sleep Through the Lens of Cellular Medicine
In this episode of Rabbit Holes, Dr. Seeds discusses how light exposure, thermal regulation, and autonomic signaling influence sleep, circadian rhythm, and mitochondrial health through the lens of cellular medicine.
Preview Only — Become a member for full access
SSRP Institute
Mar 11, 2026
SSRP Institute Announces Troscriptions as New Trusted Partner
WILLOUGHBY, Ohio, [Mar 11, 2026] — The SSRP Institute today announced the addition of Troscriptions as its newest Trusted Partner, following nomination by SSRP Fellow Dr. Elizabeth Yurth and upon completion of the organization’s internal clinical review and vetting process. Troscriptions offers physician-formulated, pharmaceutical grade, precision-dosed health optimization formulations delivered through a buccal troche. This […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Mar 9, 2026
Ep. 078 - The Effects of AG1® Supplementation on the Gut Microbiome of Healthy Adults
Preview Only
Journal Club – Episode 078
The Effects of AG1® Supplementation on the Gut Microbiome of Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Dr. Seeds reviews a randomized controlled study on AG1 and its potential impact on the gut microbiome. The research shows short-term probiotic survival and safety but no significant changes in microbiome diversity or systemic metabolic effects. Dr. Seeds discusses what the study supports, what it doesn’t, and why careful interpretation of research matters in clinical practice. (Article Link)
Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Mar 2, 2026
Ep. 077 - March '26
Preview Only
Dr. Seeds’ Office Hours – Episode 077
1. Post-chemotherapy fatigue and neuropathy in a colorectal cancer survivor peptide safety and immune support (0:48)
2. Severe food reactivity with mast cell involvement and redox imbalance (07:50)
3. Severe pediatric JIA with MIS-C and persistent hyperinflammation (23:34)
Preview Only — Become a member for full access
William Seeds, MD
Feb 26, 2026
The Role of Spermidine and Endothelial Regeneration
Recently I presented a Rabbit Hole (1/19/2026) related to the polyamine, spermidine, in response to a 2025 article, “Polyamines sustain epithelial regeneration in aged intestines by modulating protein homeostasis,” which appeared in Nature Cell Biology. I was fascinated by the premise of this study because it not only provides a mechanistic way of looking at […]
READ ARTICLE
SSRP Institute
Feb 26, 2026
Tracking the History of Cells
In a paper published in the January 2026 issue of Science, scientists at the Harvard-MIT Broad Institute recently developed a technique called TimeVault, which turns naturally occurring cellular “vault” particles into tiny intracellular time capsules that store a lasting record of past gene expression. By engineering vault-forming proteins to capture messenger RNA (via poly(A)-binding proteins), […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Feb 23, 2026
Ep. 076 - Rethinking OCD Through a Cellular Medicine Lens
Preview Only
Dissecting Protocols – Episode 076
Rethinking OCD Through a Cellular Medicine Lens
Dr. Seeds explores OCD as a circuitry and maladaptive learning issue, discussing neurotransmitter balance, oxidative stress, and mitochondrial function while highlighting a non-SSRI approach that pairs cellular support with ERP to promote lasting change. Question Link
Preview Only — Become a member for full access